ENdometrial cancer SURvivors' follow-up carE (ENSURE): Less is more? Randomized controlled trial to evaluate patient satisfaction and cost-effectiveness of a reduced follow-up schedule
- Conditions
- endometrial canceruterine cancer10046828
- Registration Number
- NL-OMON44746
- Lead Sponsor
- niversiteit van Tilburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 282
1. Patients with Endometrioïd type endometrial carcinoma with stage 1 (FIGO, 2009) disease, with the following combination of stage, age and grade:
- Stage 1A, any age, grade 1 or 2;
- Stage 1B, < 60 years, grade 1 or 2 without LVS
2. Written informed consent
3. Sufficiënt oral and written command of the Dutch language
1. Any other stage and type of endometrial carcinoma
2. Histological types papillary serous carcinoma or clear cell carcinoma
3. Uterine sarcoma (including carcinosarcoma)
4. Radiotherapy for current endometrial carcinoma
5. Previous malignancy (except for non-melanomatous skin cancer) < 5 yrs
6. Confirmed Lynch syndrome
7. Previous pelvic radiotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcomes:<br /><br>1. Patient satisfaction with follow-up care (at 6, 12, 36 and 60 months after<br /><br>completion of primary treatment)<br /><br>2. Costs-effectiveness from the health care perspective (after 3 and 5 years.)</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcomes:<br /><br>• Health care use -gynaecologist, (specialist) nurse, primary care physician<br /><br>and other health or care services-; adherence to the indicated follow-up<br /><br>protocols; reasons for non-adherence<br /><br>• HRQoL, worry including fear of recurrence, anxiety and depression, and<br /><br>satisfaction with information provision<br /><br>• Health care providers* satisfaction with follow-up schedule (gynaecologist,<br /><br>(specialised) nurse)<br /><br>• Time till recurrence and survival.</p><br>